When switching an adult patient from eplerenone 25 mg daily to spironolactone, what initial dose and timing should be used, and how should the dose be titrated?

Switching from Eplerenone 25 mg to Spironolactone

When switching from eplerenone 25 mg daily to spironolactone, start spironolactone at 25 mg once daily immediately after stopping eplerenone, as these are equipotent starting doses per guideline recommendations. 1, 2, 3, 4

Initial Dose and Timing

The ESC guidelines explicitly state that both spironolactone and eplerenone share the same starting dose of 25 mg once daily 1. The FDA labels confirm this equivalence at initiation 3, 4. Therefore:

• Stop eplerenone 25 mg
• Start spironolactone 25 mg once daily the next day
• No washout period is necessary, as both drugs have similar mechanisms and the patient is already on mineralocorticoid receptor antagonist therapy

Pre-Switch Requirements

Before making the switch, verify 1, 2:

• Serum potassium <5.0 mEq/L
• eGFR >30 mL/min/1.73 m² (ideally >50 mL/min/1.73 m²)
• Adequate renal function (creatinine <220 μmol/L or 2.5 mg/dL)

If the patient was tolerating eplerenone 25 mg without hyperkalemia or renal dysfunction, they should tolerate spironolactone 25 mg similarly.

Monitoring Schedule After Switch

Critical monitoring timeline 1, 2, 5:

• Week 1: Check potassium and creatinine
• Week 4: Recheck potassium and creatinine
• If stable, continue monitoring at 1,2,3, and 6 months
• Then every 6 months thereafter

Dose Titration Strategy

After 4-8 weeks on spironolactone 25 mg daily, consider uptitration to the target dose 1, 2:

Target dose: 50 mg once daily (evidence-based dose from RALES trial)

Titration criteria:

• Proceed with uptitration if:

  • Potassium remains <5.0 mEq/L
  • No worsening renal function
  • Patient tolerating current dose

• Hold or reduce dose if:

  • Potassium 5.5-5.9 mEq/L: Reduce to 25 mg every other day
  • Potassium ≥6.0 mEq/L: Stop immediately and monitor closely 1, 5
  • Creatinine rises to >220 μmol/L (2.5 mg/dL): Reduce to 25 mg every other day
  • Creatinine >310 μmol/L (3.5 mg/dL): Stop immediately 1

Important Considerations About Potency

While both drugs start at 25 mg, spironolactone is approximately 4.5 times more potent than eplerenone for blood pressure reduction 6. This means eplerenone 25 mg is roughly equivalent to spironolactone 5-6 mg in antihypertensive effect. However, the guidelines recommend starting both at 25 mg because:

1. The 25 mg dose of spironolactone was the proven starting dose in the landmark RALES trial 1
2. Both drugs have similar hyperkalemia risk at their respective starting doses 6, 7
3. Clinical outcomes data support 25 mg as the appropriate starting dose for both agents 5, 8

Common Pitfalls to Avoid

Gynecomastia risk: Spironolactone causes breast tenderness/enlargement in approximately 10% of men (vs. rare with eplerenone) 1. If this develops, switch back to eplerenone or consider alternative therapy.

Don't combine with:

• ACE inhibitor AND ARB together (increases hyperkalemia risk) 1
• Potassium supplements without careful monitoring
• NSAIDs if possible (increases hyperkalemia risk) 3

Renal impairment: If eGFR is 30-50 mL/min/1.73 m², consider starting at 25 mg every other day instead 4, 5

Drug interactions: If patient is on moderate CYP3A inhibitors (erythromycin, fluconazole, verapamil), this doesn't affect spironolactone dosing (unlike eplerenone which requires dose reduction) 3

Why This Switch Might Be Made

The most common reason for switching from eplerenone to spironolactone is cost, as spironolactone is significantly less expensive. Other reasons include:

• Eplerenone unavailability
• Insurance formulary requirements
• Spironolactone has stronger evidence in resistant hypertension 9

The switch is generally safe and straightforward when proper monitoring is maintained 8, 7.